Evidence map›Paper›PMID 27220339›Full record

ArticleWiener klinische Wochenschrift2016

Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.

Branka Bedenić, Nataša Firis, Vesna Elveđi-Gašparović, Marija Krilanović, Krešimir Matanović, Iva Štimac, Josefa Luxner, Jasmina Vraneš, Tomislav Meštrović, Gernot Zarfel and 1 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Outbreak Caused by VIM-1- and VIM-4-PositivePathogens (Basel, Switzerland) · 2025
    Article
  2. First Report of CTX-M-32 and CTX-M-101 inAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Branka BedenićDepartment of Microbiology, School of Medicine, University of Zagreb, Šalata 3, Zagreb, Croatia. branka.bedenic@kbc-zagreb.hr.
Nataša FirisClinical Department for Clinical and Molecular Microbiology, Clinical Hospital Centre Zagreb, Kišpatićeva 12, 10000, Zagreb, Croatia.
Vesna Elveđi-GašparovićDepartment for Gynecology and Obstetrics, School of Medicine, University of Zagreb, University Hospital Center Zagreb, Zagreb, Croatia.
Marija KrilanovićDepartment for Microbiology, Public Health Institute of Dubrovnik-Neretva County, Dubrovnik, Croatia.
Krešimir MatanovićDepartment of Microbiology and Infectious Diseases with Clinic, Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia.
Iva ŠtimacDepartment of Microbiology and Infectious Diseases with Clinic, Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia.
Josefa LuxnerInstitute for Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
Jasmina VranešZagreb Institute of Public Health "Andrija Štampar", School of Medicine, University of Zagreb, Zagreb, Croatia.
Tomislav MeštrovićPolyclinic "Dr Zora Profozić", Zagreb, Croatia.
Gernot ZarfelInstitute for Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
Andrea GrisoldInstitute for Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
Medical University of Graz · ATUniversity of Zagreb · HRUniversity Hospital Centre Zagreb · HRAndrija Stampar Teaching Institute of Public Health · HRUniversity of Dubrovnik · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn increased frequency of Proteus mirabilis isolates resistant to expanded-spectrum cephalosporins was observed recently in a long-term care facility in Zagreb (Godan). The aim of this study was the molecular characterization of resistance mechanisms to new cephalosporins in P. mirabilis isolates from this nursing home.

methodsThirty-eight isolates collected from 2013-2015 showing reduced susceptibility to ceftazidime were investigated. Antibiotic susceptibilities were determined by broth microdilution method. Inhibitor-based tests were performed to detect extended-spectrum (ESBLs) and AmpC β-lactamases. AmpC β-lactamases were characterized by polymerase chain reaction (PCR) followed by sequencing of bla ampC genes. Quinolone resistance determinants (qnr genes) were characterized by PCR. Genotyping of the isolates was performed by repetitive element sequence (rep)-PCR and pulsed-field gel electrophoresis (PFGE).

resultsPresence of an AmpC β-lactamase was confirmed in all isolates by combined-disk test with phenylboronic acid. All isolates were resistant to amoxicillin alone and combined with clavulanate, cefotaxime, ceftriaxone, cefoxitin, and ciprofloxacin; but susceptible to cefepime, imipenem, and meropenem. PCR followed by sequencing using primers targeting bla ampc genes revealed CMY-16 β-lactamase in all but one strain. Bla cmy-16 was carried by a non-conjugative plasmid which did not belong to any known plasmid-based replicon typing (PBRT) group. Rep-PCR identified one large clone consisting of 15 isolates, three pairs or related isolates, one triplet, and four singletons. PFGE confirmed the clonality of the isolates.

conclusionsThis is the first report of multidrug resistant P. mirabilis in a nursing home in Croatia. Cephalosporin resistance was due to plasmid-mediated AmpC β-lactamase CMY-16.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCommunicable Diseases, EmergingCroatiaDisease SusceptibilityDrug Resistance, Multiple, BacterialHumansLong-Term CareNursing HomesProteus InfectionsProteus mirabilisSpecies SpecificityAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesAmpC β-lactamasesClonal disseminationCMY-16Conjugative plasmidProteus mirabilis

Identifiers

PMID27220339
OpenAlexW2343256280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.